We are live on ! Find out more
BCC

Bridge City Capital Portfolio holdings

AUM $361M
1-Year Est. Return 38.29%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+38.29%
3 Year Est. Return
+76.88%
5 Year Est. Return
+81.43%
10 Year Est. Return
AUM
$298M
AUM Growth
+$23M
Cap. Flow
+$28M
Cap. Flow %
9.4%
Top 10 Hldgs %
23.54%
Holding
113
New
3
Increased
101
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
FN icon
Fabrinet
FN
+$2.29M
2
THRM icon
Gentherm
THRM
+$2.19M
3
ENSG icon
The Ensign Group
ENSG
+$1.7M
4
TTEK icon
Tetra Tech
TTEK
+$1.58M
5
AIN icon
Albany International
AIN
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 25.23%
2 Healthcare 21.48%
3 Industrials 20.4%
4 Consumer Discretionary 11.52%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOPE icon
76
Hope Bancorp
HOPE
$1.79B
$1.8M 0.61%
167,736
+331
+0.2% +$3.49K
ZYXI
77
DELISTED
Zynex
ZYXI
$1.8M 0.61%
193,289
+6,624
+4% +$70.5K
SYNA icon
78
Synaptics
SYNA
$4.14B
$1.69M 0.57%
19,131
+39
+0.2% +$3.53K
JACK icon
79
Jack in the Box
JACK
$335M
$1.67M 0.56%
32,861
+910
+3% +$51.1K
CORT icon
80
Corcept Therapeutics
CORT
$11.9B
$1.6M 0.54%
49,237
-401
-0.8% -$11K
HCSG icon
81
Healthcare Services Group
HCSG
$1.54B
$1.55M 0.52%
146,274
+288
+0.2% +$3.19K
ACIW icon
82
ACI Worldwide
ACIW
$5.46B
$1.54M 0.52%
39,016
+76
+0.2% +$2.65K
ONTO icon
83
Onto Innovation
ONTO
$15.1B
$1.52M 0.51%
6,929
-11,659
-63% -$2.41M
AMN icon
84
AMN Healthcare
AMN
$1.39B
$1.51M 0.51%
29,556
+11,931
+68% +$676K
RES icon
85
RPC Inc
RES
$1.29B
$1.5M 0.51%
240,665
+478
+0.2% +$3.34K
BOOM icon
86
DMC Global
BOOM
$159M
$1.45M 0.49%
100,776
+2,190
+2% +$32.6K
CWT icon
87
California Water Service
CWT
$3.12B
$1.42M 0.48%
29,301
+58
+0.2% +$2.82K
UFPT icon
88
UFP Technologies
UFPT
$2.43B
$1.35M 0.46%
+5,134
New +$1.27M
LTC
89
LTC Properties
LTC
$2.15B
$1.3M 0.44%
37,759
+75
+0.2% +$2.5K
CCSI icon
90
Consensus Cloud Solutions
CCSI
$668M
$1.11M 0.37%
64,367
+6,790
+12% +$110K
SSTK icon
91
Shutterstock
SSTK
$217M
$1M 0.34%
25,954
+52
+0.2% +$2.11K
MD icon
92
Pediatrix Medical
MD
$2.2B
$974K 0.33%
128,978
+258
+0.2% +$2.13K
OMCL icon
93
Omnicell
OMCL
$1.7B
$929K 0.31%
34,324
+69
+0.2% +$2K
CMBM
94
DELISTED
Cambium Networks
CMBM
$766K 0.26%
274,656
+6,425
+2% +$22.5K
CRAI icon
95
CRA International
CRAI
$1.12B
$746K 0.25%
4,333
-477
-10% -$77.2K
MYRG icon
96
MYR Group
MYRG
$5.26B
$674K 0.23%
4,967
+671
+16% +$105K
CHRS icon
97
Coherus Oncology
CHRS
$194M
$547K 0.18%
316,009
+625
+0.2% +$1.26K
PKE icon
98
Park Aerospace
PKE
$817M
$488K 0.16%
35,641
+7,059
+25% +$102K
PAYS icon
99
Paysign
PAYS
$698M
$479K 0.16%
111,249
+8,848
+9% +$39K
CMCO icon
100
Columbus McKinnon
CMCO
$587M
$425K 0.14%
12,302
+1,663
+16% +$67.5K

Similar funds

Bridge City Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Bridge City Capital held 113 positions worth $298M, up 8.4% from $275M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bridge City Capital deployed $28M of net new capital in Q2 2024, opening 3 new positions and adding to 101 existing holdings. Its largest new stake was Fabrinet: 10,799 shares worth $2.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Onto Innovation, an estimated $2.41M trimmed.

  • Bridge City Capital's largest Q2 2024 buy was Fabrinet: 10,799 shares worth $2.64M.
  • Bridge City Capital added most to Gentherm in Q2 2024, an estimated $2.19M increase.
  • Bridge City Capital's biggest Q2 2024 reduction was Onto Innovation, cutting an estimated $2.41M.
  • Bridge City Capital fully exited Phibro Animal Health in Q2 2024, selling an estimated $1.78M.
  • Bridge City Capital's ten largest holdings make up 24% of its $298M portfolio in Q2 2024.
  • Bridge City Capital opened 3 new positions and closed 3 in Q2 2024.
  • Bridge City Capital's portfolio value rose 8.4% quarter-over-quarter to $298M.

Based on Bridge City Capital's 13F filing for Q2 2024, filed 13 Aug 2024.